相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells
Seiichiro Sakao et al.
FASEB JOURNAL (2007)
Use of consomic rats for genomic insights into ventilator-associated lung injury
Stephanie A. Nonas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Medical therapy for pulmonary arterial hypertension - Updated ACCP evidence-based clinical practice guidelines
David B. Badesch et al.
CHEST (2007)
Combined inhibition of tyrosine- and serine-/threonine kinases in pulmonary hypertension: Sorafenib prevents vascular and myocardial remodeling
M. Klein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: Current status and future directions
Brian I. Rini
CLINICAL CANCER RESEARCH (2007)
Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?
Francoise Dignat-George et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Biological aspects and binding strategies of vascular endothelial growth factor in renal cell carcinoma
Brian I. Rini et al.
CLINICAL CANCER RESEARCH (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: A review of four phase I trials in patients with advanced refractory solid tumors
Dirk Strumberg et al.
ONCOLOGIST (2007)
Future aspects of the treatment of pulmonary arterial hypertension
H. A. Ghofrani et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2006)
Treatment of pulmonary arterial hypertension with phosphodiesterase-5 inhibitors
H. A. Ghofrani et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2006)
Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)
Danielle A. Murphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies
Hossein A. Ghofrani et al.
CARDIOVASCULAR RESEARCH (2006)
Pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
CIRCULATION (2006)
High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension
Joy D. Cogan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
P38 Mitogen-activated protein kinase mediates the sustained phase of hypoxic pulmonary vasoconstriction and plays a role in phase I vasodilation
Eric D. Morrell et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension
Karen C. Patterson et al.
ANNALS OF INTERNAL MEDICINE (2006)
The place of VEGF inhibition in the current management of renal cell carcinoma
P Nathan et al.
BRITISH JOURNAL OF CANCER (2006)
Reverse remodeling - paradigm shift in the treatment of pulmonary hypertension
HA Ghofrani et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2006)
Mechanisms of hypertension associated with BAY 43-9006
ML Veronese et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Vascular endothelial growth factor (VEGF)-receptor2: Its biological functions, major signaling pathway, and specific ligand VEGF-E
Masabumi Shibuya
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
Physiogenomic resources for rat models of heart, lung and blood disorders
RL Malek et al.
NATURE GENETICS (2006)
Pulmonary arterial hypertension
A Raiesdana et al.
ANNALS OF MEDICINE (2006)
Prostacyclin synthase promoter regulation and familial pulmonary arterial hypertension
P Nana-Sinkam et al.
CHEST (2005)
Differential gene expression in chronic hypoxic pulmonary hypertension - Effect of simvastatin treatment
RE Girgis et al.
CHEST (2005)
Microarray analysis of peripheral blood cells in pulmonary arterial hypertension, surrogate to biopsy
TM Bull et al.
CHEST (2005)
Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and α-actinin
PA Singleton et al.
FASEB JOURNAL (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Global gene annotation analysis and transcriptional profiling identify key biological modules in hypoxic pulmonary hypertension
SA Gharib et al.
PHYSIOLOGICAL GENOMICS (2005)
Considerations when using the significance analysis of microarrays (SAM) algorithm
O Larsson et al.
BMC BIOINFORMATICS (2005)
Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells
S Sakao et al.
FASEB JOURNAL (2005)
Hypoxic pulmonary vasoconstriction
R Moudgil et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Effects of endogenous carbon monoxide on collagen synthesis in pulmonary artery in rats under hypoxia
LM Gong et al.
LIFE SCIENCES (2004)
Endothelial dysfunction in pulmonary hypertension
R Budhiraja et al.
CIRCULATION (2004)
A model-based background adjustment for oligonucleotide expression arrays
ZJ Wu et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2004)
Prolonged nitric oxide inhalation fails to regress hypoxic vascular remodeling in rat lung
BH Jiang et al.
CHEST (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
PubMatrix: a tool for multiplex literature mining
KG Becker et al.
BMC BIOINFORMATICS (2003)
Attenuation of chronic hypoxic pulmonary hypertension by simvastatin
RE Girgis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Recent advances in pulmonary vascular disease
I Adatia
CURRENT OPINION IN PEDIATRICS (2002)
Profiling gene expression using onto-express
P Khatri et al.
GENOMICS (2002)
Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis
RM Tuder et al.
JOURNAL OF PATHOLOGY (2001)
Chronic hypoxia induces constitutive p38 mitogen-activated protein kinase activity that correlates with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries
DJ Welsh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Gene expression patterns in the lungs of patients with primary pulmonary hypertension - A gene microarray analysis
MW Geraci et al.
CIRCULATION RESEARCH (2001)
Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
L Taraseviciene-Stewart et al.
FASEB JOURNAL (2001)
Genomic approaches to research in pulmonary hypertension
MW Geraci et al.
RESPIRATORY RESEARCH (2001)
Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats
N Nagaya et al.
CIRCULATION (2000)
分享论文
